Clark Kenneth A bought SMMT
January 2, 2026 · Form 4 insider transaction
Clark Kenneth A bought 17,796 shares of Summit Therapeutics Inc. at $8.76 per share, a transaction worth $155.9K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,796
Price
$8.76
Total value
$155.9K
InsiderClark Kenneth A
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after17,796
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $155,900.; The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date.